<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Quinazolinone &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/quinazolinone/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 18 Oct 2026 14:22:51 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Quinazolinone &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Computational Study Identifies Quinazolinone Derivatives as HDAC8 Leads</title>
		<link>https://bioengineer.org/computational-study-identifies-quinazolinone-derivatives-as-hdac8-leads/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sun, 18 Oct 2026 14:22:51 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[ADME]]></category>
		<category><![CDATA[derivatives]]></category>
		<category><![CDATA[docking]]></category>
		<category><![CDATA[dynamics]]></category>
		<category><![CDATA[HDAC8]]></category>
		<category><![CDATA[hydroxamate]]></category>
		<category><![CDATA[inhibitors]]></category>
		<category><![CDATA[integrated]]></category>
		<category><![CDATA[molecular]]></category>
		<category><![CDATA[potential]]></category>
		<category><![CDATA[Quinazolinone]]></category>
		<category><![CDATA[scientific research]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=434946</guid>

					<description><![CDATA[Cancer remains one of the most significant challenges in modern medicine, characterized by uncontrolled cellular proliferation and complex molecular heterogeneity. While traditional therapies have made substantial progress, the need for novel agents with improved selectivity and efficacy continues to drive]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">434946</post-id>	</item>
	</channel>
</rss>
